Form 8-K - Current report:
SEC Accession No. 0001213900-14-009129
Filing Date
2014-12-24
Accepted
2014-12-24 16:17:25
Documents
1
Period of Report
2014-12-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 ACTINIUM PHARMACEUTICALS, INC. FORM 8-K f8k122214_actiniumpharm.htm 8-K 23565
  Complete submission text file 0001213900-14-009129.txt   24726
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 141310336
SIC: 2834 Pharmaceutical Preparations